Novartis AG (NOVN.SW)
CHF 88.04
(-0.77%)
CHF 88.04
(-0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 46.66 Billion | 51.82 Billion | 52.87 Billion | 49.89 Billion | 48.67 Billion | 53.16 Billion |
| Cost of Revenue | 12.47 Billion | 15.48 Billion | 15.86 Billion | 15.12 Billion | 14.42 Billion | 18.4 Billion |
| Gross Profit | 34.18 Billion | 36.34 Billion | 37.01 Billion | 34.77 Billion | 34.25 Billion | 34.75 Billion |
| Operating Expenses | 24.41 Billion | 27.14 Billion | 25.32 Billion | 24.62 Billion | 25.16 Billion | 26.59 Billion |
| Selling, General and Administrative Expenses | 12.51 Billion | 14.25 Billion | 14.88 Billion | 14.19 Billion | 14.36 Billion | 16.47 Billion |
| Research and Development Expenses | 11.37 Billion | 9.99 Billion | 9.54 Billion | 8.98 Billion | 9.4 Billion | 9.07 Billion |
| Other Expenses | 531 Million | 2.89 Billion | 895 Million | 1.44 Billion | 1.39 Billion | 1.04 Billion |
| Cost and Expenses | 36.89 Billion | 42.63 Billion | 41.18 Billion | 39.74 Billion | 39.59 Billion | 44.99 Billion |
| Operating Income | 9.76 Billion | 9.19 Billion | 26.94 Billion | 10.15 Billion | 9.08 Billion | 8.16 Billion |
| Interest Expense | 855 Million | 837 Million | 811 Million | 869 Million | 850 Million | 957 Million |
| Income Tax Expense | 551 Million | 1.41 Billion | 2.11 Billion | 1.8 Billion | 1.79 Billion | 1.22 Billion |
| Earnings before Tax | 9.12 Billion | 8.37 Billion | 26.13 Billion | 9.87 Billion | 8.94 Billion | 13.83 Billion |
| Net Income | 14.85 Billion | 6.95 Billion | 24.02 Billion | 8.07 Billion | 7.14 Billion | 12.61 Billion |
| Earnings Per Share Basic | 7.11 | 3.19 | 10.71 | 3.55 | 3.12 | 5.44 |
| Earnings Per Share Diluted | 7.10 | 3.17 | 10.63 | 3.52 | 3.08 | 5.38 |
| Weighted Average Shares Outstanding | 2.08 Billion | 2.18 Billion | 2.24 Billion | 2.27 Billion | 2.29 Billion | 2.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.09 Billion | 2.19 Billion | 2.26 Billion | 2.29 Billion | 2.31 Billion | 2.34 Billion |
| Gross Margin | 0.73 | 0.70 | 0.70 | 0.70 | 0.70 | 0.65 |
| EBIT Margin | 0.39 | 0.32 | 0.63 | 0.34 | 0.32 | 0.41 |
| Profit Margin | 0.32 | 0.13 | 0.45 | 0.16 | 0.15 | 0.24 |
| EBITDA | 18.25 Billion | 14.68 Billion | 30.91 Billion | 17.21 Billion | 15.61 Billion | 20.23 Billion |
| Earnings Before Tax Margin | 0.21 | 0.18 | 0.51 | 0.20 | 0.19 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 13.17 Billion | 12.87 Billion | 12.12 Billion | 46.66 Billion | 11.77 Billion | 12.09 Billion |
| Cost of Revenue | 3.23 Billion | 3.17 Billion | 3.09 Billion | 12.47 Billion | 3.02 Billion | 3.11 Billion |
| Gross Profit | 9.93 Billion | 9.69 Billion | 9.02 Billion | 34.18 Billion | 8.75 Billion | 8.97 Billion |
| Operating Expenses | 6.31 Billion | 5.68 Billion | 5.65 Billion | 24.41 Billion | 6.17 Billion | 7.21 Billion |
| Selling, General and Administrative Expenses | 3.13 Billion | 3.09 Billion | 2.84 Billion | - | 3.44 Billion | 3.09 Billion |
| Research and Development Expenses | 2.39 Billion | 2.36 Billion | 2.42 Billion | - | 2.56 Billion | 3.92 Billion |
| Other Expenses | 785 Million | 227 Million | - | - | - | - |
| Cost and Expenses | 9.54 Billion | 8.85 Billion | 8.74 Billion | 36.89 Billion | 9.19 Billion | 10.33 Billion |
| Operating Income | 3.62 Billion | 4.01 Billion | 3.37 Billion | 9.76 Billion | 2.58 Billion | 1.76 Billion |
| Interest Expense | 264 Million | 246 Million | 221 Million | 855 Million | 217 Million | 222 Million |
| Income Tax Expense | 200 Million | 595 Million | 441 Million | 551 Million | -261 Million | 39 Million |
| Earnings before Tax | 3.38 Billion | 3.84 Billion | 3.12 Billion | 9.12 Billion | 2.37 Billion | 1.55 Billion |
| Net Income | 3.18 Billion | 3.24 Billion | 2.68 Billion | 14.85 Billion | 8.48 Billion | 1.76 Billion |
| Earnings Per Share Basic | 1.37 | 1.60 | 1.31 | - | 4.14 | 0.85 |
| Earnings Per Share Diluted | 1.36 | 1.59 | 1.31 | - | 4.11 | 0.85 |
| Weighted Average Shares Outstanding | 2.01 Billion | 2.04 Billion | 2.04 Billion | 2.07 Billion | 2.05 Billion | 2.06 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 2.04 Billion | 2.05 Billion | 2.09 Billion | 2.06 Billion | 2.07 Billion |
| Gross Margin | 0.75 | 0.75 | 0.74 | 0.73 | 0.74 | 0.74 |
| EBIT Margin | 0.43 | 0.41 | 0.38 | - | 0.36 | 0.40 |
| Profit Margin | 0.24 | 0.25 | 0.22 | 0.32 | 0.72 | 0.15 |
| EBITDA | 5.61 Billion | 5.24 Billion | 4.66 Billion | - | 4.18 Billion | 4.88 Billion |
| Earnings Before Tax Margin | 0.28 | 0.31 | 0.28 | 0.21 | 0.22 | 0.15 |
TOFB
BEAN
HLKKF
ELMN
CNTR
0918